EMP2 regulates angiogenesis in endometrial cancer cells through induction of VEGF

Hypoxia-Inducible Factors in Physiology and Medicine

(2012) Gregg L. Semenza   CELL

Growing tumor vessels: More than one way to skin a cat – Implications for angiogenesis targeted cancer therapies

(2011) Rodrigo Leite de Oliveira et al.   MOLECULAR ASPECTS OF MEDICINE

Tumor Angiogenesis and Vascular Patterning: A Mathematical Model

(2011) Rui D. M. Travasso et al.   PLoS One

Epithelial Membrane Protein-2 Promotes Endometrial Tumor Formation through Activation of FAK and Src

(2011) Maoyong Fu et al.   PLoS One

Epithelial membrane protein-2 expression is an early predictor of endometrial cancer development

(2010) Omar Habeeb et al.   CANCER

Epithelial Membrane Protein-2 Is a Novel Therapeutic Target in Ovarian Cancer

(2010) M. Fu et al.   CLINICAL CANCER RESEARCH

In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract

(2010) Irina Arnaoutova et al.   Nature Protocols

The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo

(2010) G Merdzhanova et al.   ONCOGENE

Fyn and Src Are Effectors of Oncogenic Epidermal Growth Factor Receptor Signaling in Glioblastoma Patients

(2009) K. V. Lu et al.   CANCER RESEARCH

Biomechanical regulation of blood vessel growth during tissue vascularization

(2009) Witold W Kilarski et al.   NATURE MEDICINE

Diabodies Targeting Epithelial Membrane Protein 2 Reduce Tumorigenicity of Human Endometrial Cancer Cell Lines

(2008) K. Shimazaki et al.   CLINICAL CANCER RESEARCH

Sustained VEGF Blockade Results in Microenvironmental Sequestration of VEGF by Tumors and Persistent VEGF Receptor-2 Activation

(2008) A. Kadenhe-Chiweshe et al.   MOLECULAR CANCER RESEARCH

Tumor Angiogenesis

(2008) Robert S. Kerbel   NEW ENGLAND JOURNAL OF MEDICINE